A comprehensive study of the entire estrogen-metabolizing pathway (CYP17, CYP1A1, COMT) also reported that breast cancer is only associated with the low activity COMT genotype in women with a high BMI and that the COMT-LL genotype was strongly associated with breast cancer risk, with an adjusted OR of as high as 4.02[12]. Here, CYP1A1 is linked to breast carcinoma.